- Thursday, May 4, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
WelcomeCo-Chair: – University of California, Los Angeles
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Co-Chair###Professor###University of California, Los Angeles###Co-Chair: – University of California, Los Angeles
### 8:15 AM – 9:00 AM ET
Session 1: Birdseye View of the Current Treatment Landscape in Metastatic NSCLC without Actionable Mutations
8:15 AM – 9:00 AM ET
Session 1: Birdseye View of the Current Treatment Landscape in Metastatic NSCLC without Actionable MutationsPresenter: – Cedars Sinai Medical Center
Karen Reckamp, MD – Cedars Sinai Medical Center ### 799344###Presenter###Professor###Cedars Sinai Medical Center###Presenter: – Cedars Sinai Medical Center
###
9:00 AM – 9:45 AM ET
Session 2: Special Topic –EGFR Mutation
9:00 AM – 9:45 AM ET
Session 2: Upfront Treatment in Sensitizing EGFR Mutation
Heather Wakelee, MD (she/her/hers) – Stanford University ### 1047211###Presenter###Professor of Medicine and Chief of Oncology###Stanford University###Presenter: – Stanford University
### she/her/hers
9:45 AM – 10:45 AM ET
A Treatment Option for Patients With Resectable NSCLC Dual Immunotherapy + Platinum-Based Chemotherapy for the Treatment of mNSCLC
9:45 AM – 10:45 AM ET
Non-CME Innovation Theater (Sponsored by AstraZeneca)
10:45 AM – 11:00 AM ET
Exhibit Hall
10:45 AM – 11:00 AM ET
Exhibit Hall
11:00 AM – 11:45 AM ET
Session 3: EGFR: The Challenge of Primary and Secondary Resistance
11:00 AM – 11:45 AM ET
Session 3: EGFR: The Challenge of Primary and Secondary ResistancePresenter: – Memorial Sloan Kettering Cancer Center
Helena Yu, MD – Memorial Sloan Kettering Cancer Center ### 1345377###Presenter###Associate Attending###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
11:45 AM – 12:30 PM ET
Session 4: Targeting ALK and ROS1: A Fusion ParadigmPresenter: – Northwestern University
11:45 AM – 12:30 PM ET
Session 4: Targeting ALK and ROS1: A Fusion ParadigmPresenter: – Northwestern University
Jyoti Patel, MD – Northwestern University ### 1931710###Presenter###Professor###Northwestern University###Presenter: – Northwestern University
###
12:30 PM – 1:30 PM ET
The Evolving Role of Biomarkers in Advanced NSCLC - Speaker: Erin Bertino, MD
12:30 PM – 1:30 PM ET
Non-CME Innovation Theater (Sponsored by Sanofi)
1:30 PM – 2:15 PM ET
Session 5: Targeting RET, NTRK, and NRG1Presenter: – University of Chicago
1:30 PM – 2:15 PM ET
Session 5: Targeting RET, NTRK, and NRG1Presenter: – University of Chicago
Marina Garassino, MD – University of Chicago ### 1324107###Presenter###Professor of Medicine###University of Chicago###Presenter: – University of Chicago
###
2:15 PM – 3:00 PM ET
Session 6: The Emergence of ADC: Will ADCs Alter the Therapeutic Landscape?
2:15 PM – 3:00 PM ET
Session 6: The Emergence of ADC: Will ADCs Alter the Therapeutic Landscape?
Barbara Melosky, MD – Bc Cancer ### 1961092###Presenter###Medical Oncologist###Bc Cancer###Presenter: – Bc Cancer
###
3:00 PM – 3:30 PM ET
Exhibit Hall
3:00 PM – 3:30 PM ET
Exhibit Hall
3:30 PM – 4:15 PM ET
Session 7: The Primacy of Front-Line Checkpoint Inhibitors in NSCLCPresenter: – Northwestern University
3:30 PM – 4:15 PM ET
Session 7: The Primacy of Front-Line Checkpoint Inhibitors in NSCLCPresenter: – Northwestern University
Jyoti Patel, MD – Northwestern University ### 1931710###Presenter###Professor###Northwestern University###Presenter: – Northwestern University
###
4:15 PM – 5:15 PM ET
KOL Round Table
4:15 PM – 5:15 PM ET
KOL Round Table Reception Presenter: – University of California, Los Angeles
Presenter: – Rush University
Presenter: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Presenter: – Bc Cancer
Presenter: – Northwestern University
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Presenter###Professor###University of California, Los Angeles###Presenter: – University of California, Los Angeles
### @@@ Helen J. Ross, MD (she/her/hers) – Rush University ### 758420###Presenter###Thoracic Medical Oncologist, Director of Research and Clinical Trials###Rush University###Presenter: – Rush University
### she/her/hers @@@ Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Presenter###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Presenter: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his @@@ Barbara Melosky, MD – Bc Cancer ### 1961092###Presenter###Medical Oncologist###Bc Cancer###Presenter: – Bc Cancer
### @@@ Jyoti Patel, MD – Northwestern University ### 1931710###Presenter###Professor###Northwestern University###Presenter: – Northwestern University
### - Friday, May 5, 2023
8:45 AM – 9:00 AM ET
Welcome
8:45 AM – 9:00 AM ET
WelcomeCo-Chair: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Co-Chair###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Co-Chair: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his9:00 AM – 9:45 AM ET
Session 8: The Uncommon Tumors of the Thorax
9:00 AM – 9:45 AM ET
Session 8: The Uncommon Tumors of the ThoraxPresenter: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Presenter###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Presenter: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his
9:45 AM – 9:52 AM ET
Session 9: Debate: How to Handle PD-L1 <1% - Chemo + IOPresenter: – University of Chicago
9:45 AM – 9:52 AM ET
Session 9: Debate: How to Handle PD-L1 <1% - Chemo + IOPresenter: – University of Chicago
Marina Garassino, MD – University of Chicago ### 1324107###Presenter###Professor of Medicine###University of Chicago###Presenter: – University of Chicago
###
9:52 AM – 9:59 AM ET
Session 9: Debate: How to Handle PD-L1 <1% - IO CombosPresenter: – Rush University Medical Center
9:52 AM – 9:59 AM ET
Session 9: Debate: How to Handle PD-L1 <1% - IO CombosPresenter: – Rush University Medical Center
Mary Fidler, MD – Rush University Medical Center ### 1939537###Presenter###Professor of Medicne###Rush University Medical Center###Presenter: – Rush University Medical Center
###
9:59 AM – 10:06 AM ET
Session 9: Debate: How to Handle PD-L1 1-49% - Chemo + IOPresenter: – University of Chicago
9:59 AM – 10:06 AM ET
Session 9: Debate: How to Handle PD-L1 1-49% - Chemo + IOPresenter: – University of Chicago
Marina Garassino, MD – University of Chicago ### 1324107###Presenter###Professor of Medicine###University of Chicago###Presenter: – University of Chicago
###
10:06 AM – 10:13 AM ET
Session 9: Debate: How to Handle PD-L1 1-49% - IO OnlyPresenter: – Rush University Medical Center
10:06 AM – 10:13 AM ET
Session 9: Debate: How to Handle PD-L1 1-49% - IO OnlyPresenter: – Rush University Medical Center
Mary Fidler, MD – Rush University Medical Center ### 1939537###Presenter###Professor of Medicne###Rush University Medical Center###Presenter: – Rush University Medical Center
###
10:13 AM – 10:30 AM ET
Session 9: Debates: How to Handle PD-L1
10:13 AM – 10:30 AM ET
Live Q&A
Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Session Moderator###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Session Moderator: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his @@@ Marina Garassino, MD – University of Chicago ### 1324107###Panelist###Professor of Medicine###University of Chicago###Panelist: – University of Chicago
### @@@ Mary Fidler, MD – Rush University Medical Center ### 1939537###Panelist###Professor of Medicne###Rush University Medical Center###Panelist: – Rush University Medical Center
### 10:30 AM – 11:00 AM ET
Exhibit Hall
10:30 AM – 11:00 AM ET
Exhibit Hall
11:00 AM – 11:45 AM ET
Session 10: Updates from Recent Meetings
11:00 AM – 11:45 AM ET
Session 10: Updates from Recent MeetingsPresenter: – Rush University
Helen J. Ross, MD (she/her/hers) – Rush University ### 758420###Presenter###Thoracic Medical Oncologist, Director of Research and Clinical Trials###Rush University###Presenter: – Rush University
### she/her/hers
11:45 AM – 12:30 PM ET
Session 11: Unique Immune Combinations with Checkpoint InhibitorsPresenter: – University of Chicago
11:45 AM – 12:30 PM ET
Session 11: Unique Immune Combinations with Checkpoint InhibitorsPresenter: – University of Chicago
Marina Garassino, MD – University of Chicago ### 1324107###Presenter###Professor of Medicine###University of Chicago###Presenter: – University of Chicago
###
12:30 PM – 1:30 PM ET
Lunch
12:30 PM – 1:30 PM ET
Lunch
1:30 PM – 1:37 PM ET
Session 12: Debate: How to Handle PD-L1 >50% - Chemo + IO
1:30 PM – 1:37 PM ET
Session 12: Debate: How to Handle PD-L1 >50% - Chemo + IOPresenter: – Johns Hopkins University
Patrick Forde, MD – Johns Hopkins University ### 1765848###Presenter###Co-Director, Division of Upper Aerodigestive Malignancies###Johns Hopkins University###Presenter: – Johns Hopkins University
###
1:37 PM – 1:44 PM ET
Session 12: Debate: How to Handle PD-L1 >50% - IO Only
1:37 PM – 1:44 PM ET
Session 12: Debate: How to Handle PD-L1 >50% - IO OnlyPresenter: – University of California, Los Angeles
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Presenter###Professor###University of California, Los Angeles###Presenter: – University of California, Los Angeles
###
1:44 PM – 1:51 PM ET
Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
1:44 PM – 1:51 PM ET
Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - NeoadjuvantPresenter: – University of California, Los Angeles
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Presenter###Professor###University of California, Los Angeles###Presenter: – University of California, Los Angeles
###
1:51 PM – 1:58 PM ET
Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - Adjuvant
1:51 PM – 1:58 PM ET
Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - AdjuvantPresenter: – Johns Hopkins University
Patrick Forde, MD – Johns Hopkins University ### 1765848###Presenter###Co-Director, Division of Upper Aerodigestive Malignancies###Johns Hopkins University###Presenter: – Johns Hopkins University
###
1:58 PM – 2:15 PM ET
Session 12: Debates: How to Handle PD-L1 and Neoadjuvant vs Adjuvant Therapy
1:58 PM – 2:15 PM ET
Live Q&ASession Moderator: – University of California, Los Angeles
Panelist: – Johns Hopkins University
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Session Moderator###Professor###University of California, Los Angeles###Session Moderator: – University of California, Los Angeles
### @@@ Patrick Forde, MD – Johns Hopkins University ### 1765848###Panelist###Co-Director, Division of Upper Aerodigestive Malignancies###Johns Hopkins University###Panelist: – Johns Hopkins University
### 2:15 PM – 3:00 PM ET
Session 13: Advancing the Management of NSCLC: A Focus on Emerging TherapiesPresenter: – Emory University
2:15 PM – 3:00 PM ET
Session 13: Advancing the Management of NSCLC: A Focus on Emerging TherapiesPresenter: – Emory University
Ticiana Leal, MD (she/her/hers) – Emory University ### 1778151###Presenter###Associate Professor, Thoracic Medical Oncology Program###Emory University###Presenter: – Emory University
### she/her/hers
3:00 PM – 3:30 PM ET
Exhibit Hall
3:00 PM – 3:30 PM ET
Exhibit Hall
3:30 PM – 4:15 PM ET
Session 14: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLC
3:30 PM – 4:15 PM ET
Session 14: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLCPresenter: – University of California, Los Angeles
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Presenter###Professor###University of California, Los Angeles###Presenter: – University of California, Los Angeles
###
4:15 PM – 5:00 PM ET
Session 15: BRAF Mutations: Identifying and Addressing a Rare Oncogenic DriverPresenter: – Genesis Care US
4:15 PM – 5:00 PM ET
Session 15: BRAF Mutations: Identifying and Addressing a Rare Oncogenic DriverPresenter: – Genesis Care US
Edgardo Santos, MD – Genesis Care US ### 1939639###Presenter###Medical Director of Research Services-Hem/Onc Genesis Care###Genesis Care US###Presenter: – Genesis Care US
###
- Saturday, May 6, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
WelcomeCo-Chair: – University of California, Los Angeles
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Co-Chair###Professor###University of California, Los Angeles###Co-Chair: – University of California, Los Angeles
### 8:15 AM – 9:00 AM ET
Session 16: The Road from DNA to Protein: Navigating the Minefield of Expression Amplification and Mutation
8:15 AM – 9:00 AM ET
Session 16: The Road from DNA to Protein: Navigating the Minefield of Expression Amplification and MutationPresenter: – The University of Texas MD Anderson Cancer Center
Ignacio Wistuba, MD (he/him/his) – The University of Texas MD Anderson Cancer Center ### 1947025###Presenter###Professor and Chair###The University of Texas MD Anderson Cancer Center###Presenter: – The University of Texas MD Anderson Cancer Center
### he/him/his
9:00 AM – 9:45 AM ET
Session 17: Liquid vs Tissue vs Both: The Holy Grail of Molecular DiagnosticsPresenter: – Rush University Medical Center
9:00 AM – 9:45 AM ET
Session 17: Liquid vs Tissue vs Both: The Holy Grail of Molecular DiagnosticsPresenter: – Rush University Medical Center
Mary Fidler, MD – Rush University Medical Center ### 1939537###Presenter###Professor of Medicne###Rush University Medical Center###Presenter: – Rush University Medical Center
###
9:45 AM – 10:15 AM ET
Exhibit Hall
9:45 AM – 10:15 AM ET
Exhibit Hall
10:15 AM – 11:00 AM ET
Session 18: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?Presenter: – Washington University in St. Louis
10:15 AM – 11:00 AM ET
Session 18: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?Presenter: – Washington University in St. Louis
Daniel Morgensztern, MD – Washington University in St. Louis ### 1955611###Presenter###Professor of Medicine###Washington University in St. Louis###Presenter: – Washington University in St. Louis
###
11:00 AM – 11:45 AM ET
Session 19: The Power of Patient Advocacy
11:00 AM – 11:45 AM ET
Session 19: The Power of Patient AdvocacyPresenter: – Lung Cancer Foundation of America
Kim Norris – Lung Cancer Foundation of America ### 1947019###Presenter###President###Lung Cancer Foundation of America###Presenter: – Lung Cancer Foundation of America
###
11:45 AM – 12:30 PM ET
Lunch
11:45 AM – 12:30 PM ET
Lunch
12:30 PM – 12:45 PM ET
Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - YesPresenter: – Northwestern Medicine West Region
12:30 PM – 12:45 PM ET
Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - YesPresenter: – Northwestern Medicine West Region
Vinai Gondi, MD – Northwestern Medicine West Region ### 1931706###Presenter###Director, Radiation Oncology###Northwestern Medicine West Region###Presenter: – Northwestern Medicine West Region
###
12:45 PM – 1:00 PM ET
Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - No
12:45 PM – 1:00 PM ET
Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC - NoPresenter: – Memorial Sloan Kettering Cancer Center
Daniel Gomez, MD – Memorial Sloan Kettering Cancer Center ### 1883757###Presenter###Director of Thoracic Radiation Oncology###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
###
1:00 PM – 1:15 PM ET
Session 20: Debate: Prophylactic Cranial Irradiation (PCI) in SCLC
1:00 PM – 1:15 PM ET
Live Q&AModerator: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Panelist: – Northwestern Medicine West Region
Panelist: – Memorial Sloan Kettering Cancer Center
Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Moderator###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Moderator: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his @@@ Vinai Gondi, MD – Northwestern Medicine West Region ### 1931706###Panelist###Director, Radiation Oncology###Northwestern Medicine West Region###Panelist: – Northwestern Medicine West Region
### @@@ Daniel Gomez, MD – Memorial Sloan Kettering Cancer Center ### 1883757###Panelist###Director of Thoracic Radiation Oncology###Memorial Sloan Kettering Cancer Center###Panelist: – Memorial Sloan Kettering Cancer Center
### 1:15 PM – 1:45 PM ET
Exhibit Hall
1:15 PM – 1:45 PM ET
Exhibit Hall
1:45 PM – 2:30 PM ET
Session 21: Finally Moving Forward in SCLC: The Pace of Progress is No Longer GlacialPresenter: – Harvard Medical School, Massachusetts General Hospital
1:45 PM – 2:30 PM ET
Session 21: Finally Moving Forward in SCLC: The Pace of Progress is No Longer GlacialPresenter: – Harvard Medical School, Massachusetts General Hospital
Rebecca Heist, MD, MPH – Harvard Medical School, Massachusetts General Hospital ### 1612025###Presenter###Associate Professor of Medicine###Harvard Medical School, Massachusetts General Hospital###Presenter: – Harvard Medical School, Massachusetts General Hospital
###
2:30 PM – 3:15 PM ET
Session 22: How to Handle PS2 Patients and the Elderly
2:30 PM – 3:15 PM ET
Session 22: How to Handle PS2 Patients and the ElderlyPresenter: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Presenter###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Presenter: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his
